News
SBFMW
0.1239
0.00%
0.00
Sunshine Biopharma Q1 FY26 net loss widens to $1.24 million; sales fall 9.1% to $8.09 million
PUBT · 23h ago
Weekly Report: what happened at SBFMW last week (0504-0508)?
Weekly Report · 3d ago
Weekly Report: what happened at SBFMW last week (0427-0501)?
Weekly Report · 05/04 10:37
Weekly Report: what happened at SBFMW last week (0420-0424)?
Weekly Report · 04/27 10:41
Weekly Report: what happened at SBFMW last week (0413-0417)?
Weekly Report · 04/20 10:35
Weekly Report: what happened at SBFMW last week (0406-0410)?
Weekly Report · 04/13 10:40
Weekly Report: what happened at SBFMW last week (0330-0403)?
Weekly Report · 04/06 10:41
Sunshine Biopharma FY25 net loss widens 16.39% to $5.98 million
Reuters · 04/03 15:59
Sunshine Biopharma delays annual report filing, expects to submit within 15 days
Reuters · 03/31 20:06
Weekly Report: what happened at SBFMW last week (0323-0327)?
Weekly Report · 03/30 10:41
Weekly Report: what happened at SBFMW last week (0316-0320)?
Weekly Report · 03/23 10:37
Weekly Report: what happened at SBFMW last week (0309-0313)?
Weekly Report · 03/16 10:36
Weekly Report: what happened at SBFMW last week (0302-0306)?
Weekly Report · 03/09 10:36
Sunshine Biopharma Files Information Statement on Up to 1-for-10 Reverse Stock Split Authorization
Reuters · 03/02 21:05
Weekly Report: what happened at SBFMW last week (0223-0227)?
Weekly Report · 03/02 10:35
Weekly Report: what happened at SBFMW last week (0216-0220)?
Weekly Report · 02/23 10:35
Sunshine Biopharma Inc. held a shareholder vote on a reverse stock split
Reuters · 02/20 21:09
Sunshine Biopharma Files Draft Information Statement on Authorized Up-to-1-for-10 Reverse Stock Split Amendment
Reuters · 02/20 21:06
Weekly Report: what happened at SBFMW last week (0209-0213)?
Weekly Report · 02/16 10:35
Weekly Report: what happened at SBFMW last week (0202-0206)?
Weekly Report · 02/09 10:37
More
Webull provides a variety of real-time SBFMW stock news. You can receive the latest news about Sunshine Biopharma Inc through multiple platforms. This information may help you make smarter investment decisions.
About SBFMW
Sunshine Biopharma, Inc. is a Canada-based pharmaceutical company. The Company offers and researches life-saving medicines in a variety of therapeutic areas, including oncology and antivirals. The Company has over 32 additional generic prescription drugs. In addition, the Company is conducting a proprietary drug development program which consists of K1.1 mRNA, an mRNA-Lipid Nanoparticle targeted for liver cancer, and PLpro protease inhibitor, a small molecule for treatment of SARS Coronavirus infections. The Company operates through two segments: Prescription Generic Pharmaceuticals (Generic Pharmaceuticals) and Nonprescription Over-The-Counter Products (OTC Products). It also operates two wholly owned subsidiaries: NoraPharma Inc., which has a portfolio of pharmaceutical products consisting of approximately 61 generic prescription drugs on the market in Canada, and Sunshine Biopharma Canada Inc., which develops and sells non-prescription over-the-counter (OTC) products.